OrthopaeDenker on Twitter
Covid19-Sources
Valneva: Positive Phase 3 Results for COVID-19 Vaccine
The benefits, costs and feasibility of a low incidence COVID-19 strategy
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies
Amelie Thobaben on Twitter
ab September 2021 - Prophezeiungen der Querdenker
SARS-CoV-2 variants of concern and variants under investigation- Technical briefing 34 - technical-briefing-34-14-january-2022.pdf
Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021
Kidney Outcomes in Long COVID
Eric Feigl-Ding on Twitter
COVID vaccines safely protect pregnant people: the data are in
COVID-19 vaccine surveillance report - week 2 - Vaccine-surveillance-report-week-2-2022.pdf
SARS-CoV-2 Impfung - Mythen und Fakten
Charité-Virologe Drosten im Interview: „Wie lange geht diese Quälerei noch weiter?“
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections | NEJM
Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain
US Insurer Spending on Ivermectin Prescriptions for COVID-19
Biomarker weist frühzeitig auf schwere COVID-19-Verläufe hin
Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
Is Omicron Reinfection Possible? Here’s What Experts Want You to Know
Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
%2Fcloudfront-eu-central-1.images.arcpublishing.com%2Fmadsack%2FRPMY3GV23NEKBGKWPAGWBZGUQQ.jpg?width=92&height=&ar=&mode=&format=avif&dpr=2)
Long-Covid-Expertin warnt: „Mehrere Hunderttausend bis Millionen Menschen werden Spätfolgen haben“
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae
Eric Topol on Twitter